Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
13 hedge funds and large institutions have $1.7M invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
168% more capital invested
Capital invested by funds: $633K → $1.7M (+$1.06M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
7% less funds holding
Funds holding: 14 → 13 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$501 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIP
Almanack Investment Partners
Wayne,
Pennsylvania
|
-$14K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$11K |
| 3 |
GWI
Grace & White Inc
Ny,
New York
|
-$7.21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SL
1
Sentinus LLC
Oak Brook,
Illinois
| $1.02M | +$1.02M | +1,194,415 | New |
|
|
AA
2
Ancora Advisors
Cleveland,
Ohio
| $355K | – | – | – |
|
|
MSAM
3
Moloney Securities Asset Management
Manchester,
Missouri
| $204K | +$501 | +700 | +0.2% |
|
|
OCG
4
Opus Capital Group
Cincinnati,
Ohio
| $39K | – | – | – |
|
|
WJWM
5
Williams Jones Wealth Management
New York
| $28K | – | – | – |
|
|
LDB
6
Lee, Danner & Bass
Nashville,
Tennessee
| $14K | – | – | – |
|
|
GWI
7
Grace & White Inc
Ny,
New York
| $10K | -$7.21K | -10,600 | -42% |
|
|
AA
8
AlphaMark Advisors
Ft. Wright,
Kentucky
| $10K | – | – | – |
|
|
GG
9
Gofen & Glossberg
Chicago,
Illinois
| $9K | – | – | – |
|
|
ECM
10
Estabrook Capital Management
New York
| $5K | – | – | – |
|
|
BCWM
11
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $3.06K | – | – | – |
|
|
BC
12
Bartlett & Co
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
AIP
13
Almanack Investment Partners
Wayne,
Pennsylvania
| – | -$14K | -22,000 | Closed |
|
|
14
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$11K | -17,624 | Closed |
|
NWBO Hedge Fund Activity: Q3 2022 in Review
13 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q3 2022, worth a combined $1.7M — up 168% from $633K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NWBO and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Moloney Securities Asset Management, adding an estimated $501. The largest seller was Almanack Investment Partners, exiting entirely with an estimated $14K sold.
- 13 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q3 2022, down from 14 in Q2 2022.
- Funds reported $1.7M of Northwest Biotherapeutics, Inc. Common stock stock for Q3 2022, up 168% quarter-over-quarter.
- 1 fund opened new Northwest Biotherapeutics, Inc. Common stock positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q3 2022 was Moloney Securities Asset Management, an estimated $501 added.
- The largest Northwest Biotherapeutics, Inc. Common stock seller in Q3 2022 was Almanack Investment Partners, an estimated $14K sold.
Based on aggregated 13F filings for Q3 2022.